Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section
Status:
Recruiting
Trial end date:
2020-05-15
Target enrollment:
Participant gender:
Summary
98 pregnant women attending for CS will be randomized into 2 groups. Rectal misopristol group
who will receive 400 microgram misoprostol rectally preoperatively with urinary catheter
insertion and intrauterine misopristol group will receive 400 microgram misoprostol
intrauterine (200 microgram at each cornu) intraoperatively following the delivery of the
placenta. The estimated blood loss for each patient will be measured and data of both groups
will be compared.